๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical use of E. coli Nissle 1917 in inflammatory bowel disease

โœ Scribed by Michael Schultz

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
97 KB
Volume
14
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

โœฆ Synopsis

The probiotic Escherichia coli strain Nissle 1917 is in addition to some Lactobacilli sp. one of the best-studied probiotic strains. This particular E. coli strain was isolated in 1917 based on its potential to protect from presumably infectious gastroenteritis. Initial therapeutic success was noted in the management of gastrointestinal infectious disorders and infections affecting the urinary tract; the focus shifted later to chronic inflammatory conditions. The unique combination of fitness and survival factors to support intestinal survival, the lack of virulence, and obvious probiotic properties make this microorganism a safe and effective candidate in the treatment of chronic inflammatory bowel diseases. Three large clinical trials have assessed the potential in the maintenance of remission of ulcerative colitis and equivalence to standard 5-ASA medication was documented. This review aims to discuss important mechanisms of E. coli Nissle 1917 and will review the available literature regarding treatment of inflammatory bowel diseases.

๐Ÿ“œ SIMILAR VOLUMES

Clinical epidemiology of inflammatory bo
Clinical epidemiology of inflammatory bowel disease in Lebanon
โœ Heitham Abdul-Baki; Ihab ElHajj; Lara MN El-Zahabi; Cecilio Azar; Elie Aoun; Hal ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 148 KB ๐Ÿ‘ 2 views

## Background: The objectives of this study were to determine the prevalence and incidence of inflammatory bowel disease (ibd) in a representative lebanese cohort and to describe practice prevalence trends, disease characteristics, and impact on quality of life (qol) of ibd patients in lebanon. ##

Internet use by patients in an inflammat
Internet use by patients in an inflammatory bowel disease specialty clinic
โœ Robert R. Cima; Kari J. Anderson; David W. Larson; Eric J. Dozois; Imran Hassan; ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB ๐Ÿ‘ 1 views

## Background: Patient education is known to improve satisfaction in and participation with treatment. a careful assessment of internet use by inflammatory bowel disease (ibd) patients to gather information has not been reported. our aim was to evaluate internet use to gather general health- and di

Clinical usefulness of therapeutic drug
Clinical usefulness of therapeutic drug monitoring of thiopurines in patients with inadequately controlled inflammatory bowel disease
โœ Melissa L. Haines; Yousef Ajlouni; Peter M. Irving; Miles P. Sparrow; Rosemary R ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 155 KB ๐Ÿ‘ 1 views

Background: Circulating concentrations of 6-thioguanine nucleotide (6-TGN) and 6-methyl mercaptopurine (6-MMP) are associated with thiopurine efficacy and may predict toxicity. This study aimed to examine retrospectively the utility of measuring metabolite concentrations in patients with inflammator

Use of thiopurine testing in the managem
Use of thiopurine testing in the management of inflammatory bowel diseases in clinical practice: A worldwide survey of experts
โœ Xavier Roblin; Abderrahim Oussalah; Jean-Baptiste Chevaux; Miles Sparrow; Lauren ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 226 KB ๐Ÿ‘ 1 views

## Background: We performed a worldwide survey to evaluate the extent to which gastroenterologists who are experts in the field of inflammatory bowel diseases (IBDs) are utilizing thiopurine metabolism in practice. Methods: This was a Web-based cross-sectional survey consisting of 12 multiple-cho